TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant

NCT03110952 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped lack of materials, not moving forward

Conditions

Dengue

Interventions

BIOLOGICAL: TDENV-PIV
BIOLOGICAL: TDENV-F17
OTHER: Placebo

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]
[object Object]